EPSTEIN-BARR-VIRUS TRANSFORMATION INDUCES LYMPHOCYTES-B TO PRODUCE HUMAN INTERLEUKIN-10

被引:245
作者
BURDIN, N
PERONNE, C
BANCHEREAU, J
ROUSSET, F
机构
[1] Laboratory for Immunological Research, Sobering-Plough, Dardilly
关键词
D O I
10.1084/jem.177.2.295
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 10 (IL-10) is a pleiotropic factor that enhances proliferation of activated human B lymphocytes and induces them to secrete high amounts of immunoglobulins. Here we show that several human B cell lines were able to constitutively secrete human (h)IL-10. Whereas none of the pre-B nor the plasmocytic cell lines tested produced hIL-10, 25 of the 36 tested mature B cell lines (lymphoblastoid and Burkitt lymphoma cell lines) secreted hIL-10. Moreover, 24 of these 25 hIL-10-producing B cell lines contained the Epstein-Barr virus (EBV) genome, suggesting a relationship between hIL-10 production by human B cell lines and EBV expression. Accordingly, whereas polyclonal activation via triggering of surface immunoglobulins or CD40 antigen induced highly purified normal human B lymphocytes to produce only low (0.3-0.4 ng/ml) but significant amounts of hIL-10, EBV infection induced them to secrete high amounts of hIL-10 (4-9 ng/ml). Furthermore, addition of exogenous hIL-10, simultaneously to EBV infection, potentiated cell proliferation, whereas a blocking anti-IL-10 antiserum inhibited it. Thus, hIL-10 produced by infected human B lymphocytes appears to be involved in the mechanisms of EBV-induced B cell proliferation.
引用
收藏
页码:295 / 304
页数:10
相关论文
共 42 条
[1]   STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES [J].
ABRAMS, JS ;
RONCAROLO, MG ;
YSSEL, H ;
ANDERSSON, U ;
GLEICH, GJ ;
SILVER, JE .
IMMUNOLOGICAL REVIEWS, 1992, 127 :5-24
[2]   HUMAN-B LYMPHOCYTES - PHENOTYPE, PROLIFERATION, AND DIFFERENTIATION [J].
BANCHEREAU, J ;
ROUSSET, F .
ADVANCES IN IMMUNOLOGY, 1992, 52 :125-262
[3]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[4]  
BAUMANN MA, 1992, BLOOD, V79, P1763
[5]  
BENJAMIN D, 1992, BLOOD, V80, P1289
[6]  
BONNEFOY JY, 1989, J IMMUNOL, V143, P864
[7]   SOLUBLE CD23 IS RELEASED BY B-LYMPHOCYTES CYCLING IN RESPONSE TO INTERLEUKIN-4 AND ANTI-BP50 (CDW40) [J].
CAIRNS, J ;
FLORESROMO, L ;
MILLSUM, MJ ;
GUY, GR ;
GILLIS, S ;
LEDBETTER, JA ;
GORDON, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (03) :349-353
[8]   EPSTEIN-BARR-VIRUS (EBV) INDUCES EXPRESSION OF B-CELL ACTIVATION MARKERS ON INVITRO INFECTION OF EBV-NEGATIVE B-LYMPHOMA CELLS [J].
CALENDER, A ;
BILLAUD, M ;
AUBRY, JP ;
BANCHEREAU, J ;
VUILLAUME, M ;
LENOIR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8060-8064
[9]   INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA COOPERATE TO INDUCE ANTI-CD40 ACTIVATED NAIVE HUMAN B-CELLS TO SECRETE IMMUNOGLOBULIN-A [J].
DEFRANCE, T ;
VANBERVLIET, B ;
BRIERE, F ;
DURAND, I ;
ROUSSET, F ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :671-682
[10]  
DEFRANCE T, 1987, J IMMUNOL, V139, P1135